US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Entrada Therapeutics, Inc.

10.88

+0.08000.74%

Post-market: 10.880.00000.00%16:20 EST

Volume:183.48K

Turnover:2.00M

Market Cap:415.83M

PE:-4.33

High:11.16

Open:10.82

Low:10.55

Close:10.80

52wk High:13.82

52wk Low:4.93

Shares:38.22M

Float Shares:21.58M

Volume Ratio:1.08

T/O Rate:0.85%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-2.5151

EPS(LYR):1.68

ROE:-27.11%

ROA:-15.71%

PB:1.22

PE(LYR):6.48

Loading ...

Overview Company News Filings

Entrada Therapeutics Initiated at Buy by Guggenheim

Guggenheim Initiates Coverage on Entrada Therapeutics With Buy Rating, $20 Price Target

MT Newswires Live

Entrada Therapeutics to Present at Upcoming Investor Conferences

Oppenheimer Initiates Coverage on Entrada Therapeutics With Outperform Rating, $21 Price Target

MT Newswires Live

Entrada Therapeutics: Advancing DMD and DM1 Pipeline with Emerging Ophthalmology Assets Supports Buy Rating and $20 Target

Entrada Therapeutics unveils pipeline advances for Duchenne and myotonic dystrophy therapies

Entrada Therapeutics reports progress across development portfolio

Entrada Therapeutics Inc - Has Cash Runway Into Q3 2027

THOMSON REUTERS

Entrada Therapeutics Inc - Expects to Initiate Global Phase 1/2 Mad Clinical Study of Entr-601-50 by End of 2026

THOMSON REUTERS

Entrada Therapeutics Inc - on Track to Report Elevate-44-201 Data From First Cohort in Q2 2026 and Elevate-45-201 Data From First Cohort in Mid-2026

THOMSON REUTERS

Entrada Therapeutics Highlights Progress Across its Portfolio of RNA-based Therapeutics for the Treatment of Neuromuscular and Ocular Diseases

Entrada Therapeutics Unveils Pipeline Progress and Clinical Milestones for Duchenne and Myotonic Dystrophy Programs

Entrada Therapeutics Grants Stock Options and RSUs to New Employees Under 2025 Inducement Plan

Entrada Therapeutics CFO Kory James Wentworth Reports Disposal of Common Shares

Major Stock Sell-Offs at Entrada Therapeutics Inc!

Director and 10% Owner Kush Parmar Reports Disposal of Entrada Therapeutics Inc. Common Shares

5AM Ventures V, L.P. Reports Sale of Entrada Therapeutics Inc. Common Shares

Baker Bros. Advisors LP Acquires Common Shares of Entrada Therapeutics Inc

Promising Advancements and Strategic Positioning Drive Buy Rating for Entrada Therapeutics Inc.

BRIEF-Entrada Therapeutics may issue up to $400 million in securities - SEC filing

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/TRDA/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"TRDA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TRDA\",,,,,undefined,":{"symbol":"TRDA","market":"US","secType":"STK","nameCN":"Entrada Therapeutics, Inc.","latestPrice":10.88,"timestamp":1771016400000,"preClose":10.8,"halted":0,"volume":183478,"hourTrading":{"tag":"盘后","latestPrice":10.88,"preClose":10.88,"latestTime":"16:20 EST","volume":979,"amount":10650.26,"timestamp":1771017645065,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.007407407407407414,"floatShares":21582000,"shares":38219232,"eps":-2.51511,"marketStatus":"Closed President's Day","change":0.08,"latestTime":"02-13 16:00:00 EST","open":10.82,"high":11.16,"low":10.55,"amount":1998869.3589,"amplitude":0.056481,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.51511,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1771318800000},"marketStatusCode":7,"adr":0,"listingDate":1635480000000,"exchange":"NASDAQ","adjPreClose":10.8,"preHourTrading":{"tag":"盘前","latestPrice":10.8,"preClose":10.8,"latestTime":"08:10 EST","volume":4,"amount":43.2,"timestamp":1770988226517,"change":0,"changeRate":0,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":10.88,"preClose":10.88,"latestTime":"16:20 EST","volume":979,"amount":10650.26,"timestamp":1771017645065,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.0771837447277193,"impliedVol":0.6288,"impliedVolPercentile":0.3307},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TRDA\",,,,,undefined,":{"symbol":"TRDA","floatShares":21582000,"roa":"-15.71%","roe":"-27.11%","lyrEps":1.68,"volumeRatio":1.0771837447277193,"shares":38219232,"dividePrice":0,"high":11.16,"amplitude":0.056481,"preClose":10.8,"low":10.55,"week52Low":4.93,"pbRate":"1.22","psRate":"6.76","week52High":13.82,"institutionHeld":0,"latestPrice":10.88,"eps":-2.51511,"divideRate":0,"volume":183478,"delay":0,"ttmEps":-2.51511,"open":10.82,"prevYearClose":10.28,"prevWeekClose":10.88,"prevMonthClose":11.44,"prevQuarterClose":10.28,"fiveDayClose":10.6,"twentyDayClose":10.82,"sixtyDayClose":8.47},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TRDA\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-11-06","symbol":"TRDA","fiscalQuarterEnding":"2025/09","expectedEps":-1.04,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1762405200000,"reportTimeType":"pre","actualEps":-1.06},{"market":"US","date":"2025-08-06","symbol":"TRDA","fiscalQuarterEnding":"2025/06","expectedEps":-0.86,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1754452800000,"reportTimeType":"pre","actualEps":-1.04},{"market":"US","date":"2025-05-08","symbol":"TRDA","fiscalQuarterEnding":"2025/03","expectedEps":-0.78,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1746676800000,"reportTimeType":"pre","actualEps":-0.42},{"market":"US","date":"2025-02-27","symbol":"TRDA","fiscalQuarterEnding":"2024/12","expectedEps":-0.66,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1740632400000,"reportTimeType":"pre","actualEps":0.03},{"market":"US","date":"2024-11-05","symbol":"TRDA","fiscalQuarterEnding":"2024/09","expectedEps":-0.67,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1730782800000,"reportTimeType":"pre","actualEps":-0.35}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TRDA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"TRDA\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.6667,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":6,"updateTime":1769662800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/TRDA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"TRDA","date":"2026-02-13","current":-4.325855,"percent":0.594106,"low":-69.405148,"twenty":-7.529048,"median":-4.778229,"eighty":5.814866,"high":25.975557,"avg":-4.930241,"sd":15.352482,"marketCap":387304815},"quantilePoints":[{"date":"2021-10-29","current":-7.394936,"twenty":-17.597525,"median":-17.597525,"eighty":-11.475972,"marketCap":251013723},{"date":"2021-11-05","current":-21.790051,"twenty":-21.952046,"median":-20.803996,"eighty":-17.597525,"marketCap":739641498},{"date":"2021-11-12","current":-28.525158,"twenty":-25.58108,"median":-21.983741,"eighty":-18.485692,"marketCap":968257962},{"date":"2021-11-19","current":-28.868516,"twenty":-29.41789,"median":-24.54132,"eighty":-20.606786,"marketCap":979912918},{"date":"2021-11-26","current":-25.452541,"twenty":-28.824496,"median":-24.607351,"eighty":-21.353369,"marketCap":863961039},{"date":"2021-12-03","current":-23.533255,"twenty":-28.623764,"median":-25.505365,"eighty":-21.812942,"marketCap":798812818},{"date":"2021-12-10","current":-15.265518,"twenty":-28.187082,"median":-23.647708,"eighty":-19.069596,"marketCap":631748205},{"date":"2021-12-17","current":-11.577357,"twenty":-26.820692,"median":-22.432748,"eighty":-16.202556,"marketCap":479117339},{"date":"2021-12-23","current":-12.836913,"twenty":-26.764346,"median":-21.904504,"eighty":-14.360448,"marketCap":531242809},{"date":"2021-12-31","current":-12.912336,"twenty":-26.676305,"median":-20.53107,"eighty":-13.447835,"marketCap":534364094},{"date":"2022-01-07","current":-8.930026,"twenty":-26.218494,"median":-18.937535,"eighty":-12.769033,"marketCap":369560215},{"date":"2022-01-14","current":-6.516506,"twenty":-25.584602,"median":-17.597525,"eighty":-11.577357,"marketCap":269679075},{"date":"2022-01-21","current":-6.101682,"twenty":-25.577558,"median":-15.559666,"eighty":-10.093042,"marketCap":252512005},{"date":"2022-01-28","current":-7.021837,"twenty":-25.519451,"median":-14.360448,"eighty":-7.766209,"marketCap":290591689},{"date":"2022-02-04","current":-7.715724,"twenty":-25.463106,"median":-13.5308,"eighty":-7.379146,"marketCap":319307516},{"date":"2022-02-11","current":-8.537829,"twenty":-24.100237,"median":-13.16123,"eighty":-7.512789,"marketCap":353329529},{"date":"2022-02-18","current":-11.275667,"twenty":-23.579036,"median":-12.802973,"eighty":-7.548286,"marketCap":466632197},{"date":"2022-02-25","current":-9.126125,"twenty":-23.517408,"median":-12.086459,"eighty":-7.649352,"marketCap":377675557},{"date":"2022-03-04","current":-7.813773,"twenty":-22.862386,"median":-11.577357,"eighty":-7.720249,"marketCap":323365188},{"date":"2022-03-11","current":-6.388288,"twenty":-22.163344,"median":-11.204016,"eighty":-7.720249,"marketCap":264372890},{"date":"2022-03-18","current":-6.017184,"twenty":-21.936199,"median":-10.78542,"eighty":-7.363356,"marketCap":307827117},{"date":"2022-03-25","current":-6.255428,"twenty":-21.835832,"median":-10.117931,"eighty":-6.952448,"marketCap":320015196},{"date":"2022-04-01","current":-5.638438,"twenty":-21.46254,"median":-9.64654,"eighty":-6.638691,"marketCap":288451197},{"date":"2022-04-08","current":-4.502198,"twenty":-20.388445,"median":-9.144981,"eighty":-6.309439,"marketCap":230323437},{"date":"2022-04-14","current":-4.948141,"twenty":-19.729901,"median":-9.028075,"eighty":-6.17703,"marketCap":253137020},{"date":"2022-04-22","current":-4.107655,"twenty":-19.333718,"median":-8.726386,"eighty":-6.029276,"marketCap":210139396},{"date":"2022-04-29","current":-3.666235,"twenty":-18.754411,"median":-8.454865,"eighty":-5.912113,"marketCap":187557252},{"date":"2022-05-06","current":-3.457787,"twenty":-18.126844,"median":-8.349273,"eighty":-5.760614,"marketCap":176893461},{"date":"2022-05-13","current":-2.854496,"twenty":-17.597525,"median":-7.941992,"eighty":-5.364762,"marketCap":183969409},{"date":"2022-05-20","current":-2.883329,"twenty":-16.900041,"median":-7.813773,"eighty":-4.563286,"marketCap":185827686},{"date":"2022-05-27","current":-3.373495,"twenty":-15.618496,"median":-7.753435,"eighty":-4.36536,"marketCap":217418392},{"date":"2022-06-03","current":-3.200495,"twenty":-15.214231,"median":-7.632759,"eighty":-4.157927,"marketCap":206268731},{"date":"2022-06-10","current":-4.55566,"twenty":-14.879355,"median":-7.394936,"eighty":-4.140761,"marketCap":293607743},{"date":"2022-06-17","current":-4.11355,"twenty":-14.259382,"median":-7.131199,"eighty":-4.140761,"marketCap":265114165},{"date":"2022-06-24","current":-4.714243,"twenty":-13.855117,"median":-6.935101,"eighty":-4.15057,"marketCap":303828266},{"date":"2022-07-01","current":-5.766658,"twenty":-13.576054,"median":-6.811331,"eighty":-4.187355,"marketCap":371655372},{"date":"2022-07-08","current":-5.656131,"twenty":-13.503648,"median":-6.516506,"eighty":-4.216733,"marketCap":364531977},{"date":"2022-07-15","current":-5.209215,"twenty":-13.455377,"median":-6.350577,"eighty":-4.227922,"marketCap":335728686},{"date":"2022-07-22","current":-5.233243,"twenty":-13.218551,"median":-6.255428,"eighty":-4.255794,"marketCap":337277250},{"date":"2022-07-29","current":-6.151102,"twenty":-12.962115,"median":-6.178897,"eighty":-4.266149,"marketCap":396432396},{"date":"2022-08-05","current":-5.21402,"twenty":-12.851998,"median":-6.151102,"eighty":-4.298784,"marketCap":336038398},{"date":"2022-08-12","current":-5.083828,"twenty":-12.782609,"median":-6.05057,"eighty":-4.359782,"marketCap":395150717},{"date":"2022-08-19","current":-5.22471,"twenty":-12.238059,"median":-6.026259,"eighty":-4.396116,"marketCap":406101054},{"date":"2022-08-26","current":-5.860692,"twenty":-12.075145,"median":-5.963285,"eighty":-4.405727,"marketCap":455534002},{"date":"2022-09-02","current":-5.309239,"twenty":-11.675406,"median":-5.919443,"eighty":-4.443999,"marketCap":412671256},{"date":"2022-09-09","current":-6.005599,"twenty":-11.577357,"median":-5.919443,"eighty":-4.466633,"marketCap":466797205},{"date":"2022-09-16","current":-5.599054,"twenty":-11.396343,"median":-5.874796,"eighty":-4.487556,"marketCap":435197663},{"date":"2022-09-23","current":-6.074028,"twenty":-11.266616,"median":-5.860692,"eighty":-4.499555,"marketCap":472115940},{"date":"2022-09-30","current":-6.343716,"twenty":-11.192702,"median":-5.898062,"eighty":-4.525626,"marketCap":493078013},{"date":"2022-10-07","current":-5.961322,"twenty":-11.10672,"median":-5.888899,"eighty":-4.547138,"marketCap":463355671},{"date":"2022-10-14","current":-6.243086,"twenty":-10.903079,"median":-5.892909,"eighty":-4.553823,"marketCap":485256344},{"date":"2022-10-21","current":-7.587503,"twenty":-10.513899,"median":-5.919443,"eighty":-4.571231,"marketCap":589753842},{"date":"2022-10-28","current":-9.117079,"twenty":-10.255954,"median":-5.957297,"eighty":-4.615058,"marketCap":708643211},{"date":"2022-11-04","current":-8.909464,"twenty":-10.100584,"median":-5.973297,"eighty":-4.663727,"marketCap":692505938},{"date":"2022-11-11","current":-6.743676,"twenty":-9.96784,"median":-6.011392,"eighty":-4.695302,"marketCap":596370284},{"date":"2022-11-18","current":-6.332606,"twenty":-9.758166,"median":-6.033802,"eighty":-4.710399,"marketCap":560017708},{"date":"2022-11-25","current":-5.226969,"twenty":-9.516814,"median":-6.017184,"eighty":-4.72039,"marketCap":462241813},{"date":"2022-12-02","current":-6.488529,"twenty":-9.262707,"median":-6.011392,"eighty":-4.755372,"marketCap":573806616},{"date":"2022-12-09","current":-6.757851,"twenty":-9.16356,"median":-6.033802,"eighty":-4.809238,"marketCap":597623821},{"date":"2022-12-16","current":-7.505574,"twenty":-9.145735,"median":-6.049635,"eighty":-4.867597,"marketCap":663747905},{"date":"2022-12-23","current":-5.304931,"twenty":-9.135788,"median":-6.033802,"eighty":-4.931786,"marketCap":469136267},{"date":"2022-12-30","current":-4.791093,"twenty":-9.127349,"median":-6.017184,"eighty":-4.849836,"marketCap":423695546},{"date":"2023-01-06","current":-5.04624,"twenty":-9.126125,"median":-6.001574,"eighty":-4.798181,"marketCap":446259214},{"date":"2023-01-13","current":-4.858424,"twenty":-9.117079,"median":-5.963335,"eighty":-4.832074,"marketCap":429649847},{"date":"2023-01-20","current":-4.737938,"twenty":-9.004373,"median":-5.936357,"eighty":-4.79343,"marketCap":418994782},{"date":"2023-01-27","current":-4.273712,"twenty":-8.93926,"median":-5.907226,"eighty":-4.785423,"marketCap":377941441},{"date":"2023-02-03","current":-5.10294,"twenty":-8.913576,"median":-5.876808,"eighty":-4.726537,"marketCap":451273363},{"date":"2023-02-10","current":-5.73372,"twenty":-8.859542,"median":-5.853158,"eighty":-4.736273,"marketCap":507055765},{"date":"2023-02-17","current":-3.919341,"twenty":-8.845264,"median":-5.829192,"eighty":-4.699967,"marketCap":346603013},{"date":"2023-02-24","current":-3.926429,"twenty":-8.842391,"median":-5.815955,"eighty":-4.628083,"marketCap":347229782},{"date":"2023-03-03","current":-3.766962,"twenty":-8.772142,"median":-5.776163,"eighty":-4.547138,"marketCap":333127489},{"date":"2023-03-10","current":-4.254453,"twenty":-8.615439,"median":-5.76082,"eighty":-4.499555,"marketCap":402539289},{"date":"2023-03-17","current":-5.429059,"twenty":-8.539287,"median":-5.747436,"eighty":-4.511816,"marketCap":513675855},{"date":"2023-03-24","current":-5.271746,"twenty":-8.488051,"median":-5.734949,"eighty":-4.524607,"marketCap":498791493},{"date":"2023-03-31","current":-5.068986,"twenty":-8.454865,"median":-5.728214,"eighty":-4.53629,"marketCap":479607205},{"date":"2023-04-06","current":-4.883706,"twenty":-8.451848,"median":-5.696978,"eighty":-4.543209,"marketCap":462076735},{"date":"2023-04-14","current":-5.932462,"twenty":-8.421679,"median":-5.680564,"eighty":-4.551986,"marketCap":561305812},{"date":"2023-04-21","current":-5.257762,"twenty":-8.349273,"median":-5.670547,"eighty":-4.55566,"marketCap":497468439},{"date":"2023-04-28","current":-4.805367,"twenty":-8.340215,"median":-5.658534,"eighty":-4.562088,"marketCap":454664626},{"date":"2023-05-05","current":-4.191543,"twenty":-8.062667,"median":-5.64652,"eighty":-4.528859,"marketCap":396587028},{"date":"2023-05-12","current":-5.064425,"twenty":-7.979703,"median":-5.633268,"eighty":-4.502198,"marketCap":403224467},{"date":"2023-05-19","current":-5.277006,"twenty":-7.913544,"median":-5.617686,"eighty":-4.518228,"marketCap":420149939},{"date":"2023-05-26","current":-4.970025,"twenty":-7.90428,"median":-5.592298,"eighty":-4.528859,"marketCap":395708454},{"date":"2023-06-02","current":-4.76989,"twenty":-7.868078,"median":-5.581432,"eighty":-4.538767,"marketCap":379773885},{"date":"2023-06-09","current":-6.116634,"twenty":-7.822824,"median":-5.586978,"eighty":-4.549103,"marketCap":487000254},{"date":"2023-06-16","current":-6.016566,"twenty":-7.801706,"median":-5.597041,"eighty":-4.554742,"marketCap":479032969},{"date":"2023-06-23","current":-6.667006,"twenty":-7.789638,"median":-5.618244,"eighty":-4.559517,"marketCap":530820317},{"date":"2023-06-30","current":-6.279244,"twenty":-7.759469,"median":-5.62503,"eighty":-4.565397,"marketCap":499947091},{"date":"2023-07-07","current":-6.658667,"twenty":-7.721758,"median":-5.636859,"eighty":-4.57261,"marketCap":530156377},{"date":"2023-07-14","current":-6.737887,"twenty":-7.69008,"median":-5.655758,"eighty":-4.584244,"marketCap":536463810},{"date":"2023-07-21","current":-7.325784,"twenty":-7.579961,"median":-5.662109,"eighty":-4.599308,"marketCap":583271606},{"date":"2023-07-28","current":-6.971378,"twenty":-7.548286,"median":-5.680564,"eighty":-4.620996,"marketCap":555054140},{"date":"2023-08-04","current":-6.024905,"twenty":-7.53565,"median":-5.7162,"eighty":-4.635607,"marketCap":479696910},{"date":"2023-08-11","current":-6.317571,"twenty":-7.508508,"median":-5.728214,"eighty":-4.646146,"marketCap":520365665},{"date":"2023-08-18","current":-6.081084,"twenty":-7.503806,"median":-5.74007,"eighty":-4.685973,"marketCap":500886743},{"date":"2023-08-25","current":-6.565311,"twenty":-7.485744,"median":-5.747894,"eighty":-4.706554,"marketCap":540771554},{"date":"2023-09-01","current":-5.939851,"twenty":-7.432417,"median":-5.767385,"eighty":-4.717317,"marketCap":489253674},{"date":"2023-09-08","current":-5.90757,"twenty":-7.394936,"median":-5.767385,"eighty":-4.729611,"marketCap":486594686},{"date":"2023-09-15","current":-6.125472,"twenty":-7.334123,"median":-5.776163,"eighty":-4.737938,"marketCap":504542851},{"date":"2023-09-22","current":-5.491941,"twenty":-7.325784,"median":-5.777303,"eighty":-4.750864,"marketCap":452360224},{"date":"2023-09-29","current":-6.528994,"twenty":-7.315985,"median":-5.798618,"eighty":-4.757855,"marketCap":537780193},{"date":"2023-10-06","current":-5.891429,"twenty":-7.305739,"median":-5.815592,"eighty":-4.762744,"marketCap":485265193},{"date":"2023-10-13","current":-5.245793,"twenty":-7.264602,"median":-5.81239,"eighty":-4.76989,"marketCap":432085446},{"date":"2023-10-20","current":-5.911605,"twenty":-7.242394,"median":-5.819157,"eighty":-4.778229,"marketCap":486927060},{"date":"2023-10-27","current":-5.61098,"twenty":-7.227384,"median":-5.819157,"eighty":-4.783375,"marketCap":462165240},{"date":"2023-11-03","current":-6.323198,"twenty":-7.199866,"median":-5.83392,"eighty":-4.792261,"marketCap":520829149},{"date":"2023-11-10","current":-24.667435,"twenty":-7.289284,"median":-5.845821,"eighty":-4.795681,"marketCap":537010063},{"date":"2023-11-17","current":-23.534356,"twenty":-7.370611,"median":-5.860692,"eighty":-4.801055,"marketCap":512342934},{"date":"2023-11-24","current":-17.593348,"twenty":-7.503806,"median":-5.888899,"eighty":-4.80845,"marketCap":383007177},{"date":"2023-12-01","current":-19.859506,"twenty":-7.579961,"median":-5.902072,"eighty":-4.82304,"marketCap":432341435},{"date":"2023-12-08","current":-20.456669,"twenty":-7.795672,"median":-5.911605,"eighty":-4.834509,"marketCap":445341678},{"date":"2023-12-15","current":-21.421317,"twenty":-7.911691,"median":-5.925612,"eighty":-4.846375,"marketCap":466342072},{"date":"2023-12-22","current":-22.600332,"twenty":-8.347461,"median":-5.932462,"eighty":-4.855589,"marketCap":492009220},{"date":"2023-12-29","current":-25.126791,"twenty":-8.454865,"median":-5.939851,"eighty":-4.857715,"marketCap":547010250},{"date":"2024-01-05","current":-21.5285,"twenty":-8.540017,"median":-5.941515,"eighty":-4.868537,"marketCap":468675449},{"date":"2024-01-12","current":-24.698059,"twenty":-8.846163,"median":-5.963335,"eighty":-4.891549,"marketCap":537676742},{"date":"2024-01-19","current":-22.952505,"twenty":-8.966963,"median":-5.978768,"eighty":-4.905676,"marketCap":499676030},{"date":"2024-01-26","current":-22.814698,"twenty":-9.138499,"median":-5.992309,"eighty":-4.915832,"marketCap":496675974},{"date":"2024-02-02","current":-22.615644,"twenty":-9.581677,"median":-6.004236,"eighty":-4.91911,"marketCap":492342559},{"date":"2024-02-09","current":-22.217535,"twenty":-10.307241,"median":-6.016566,"eighty":-4.921856,"marketCap":483675730},{"date":"2024-02-16","current":-22.99844,"twenty":-11.237955,"median":-6.024748,"eighty":-4.926434,"marketCap":500676049},{"date":"2024-02-23","current":-20.272926,"twenty":-11.577357,"median":-6.028302,"eighty":-4.929152,"marketCap":441341603},{"date":"2024-03-01","current":-20.257614,"twenty":-12.836913,"median":-6.037413,"eighty":-4.93164,"marketCap":441008264},{"date":"2024-03-08","current":-19.262342,"twenty":-13.485547,"median":-6.058862,"eighty":-4.948141,"marketCap":419341191},{"date":"2024-03-15","current":-61.321385,"twenty":-15.009082,"median":-6.081084,"eighty":-4.952685,"marketCap":409933456},{"date":"2024-03-22","current":-65.487505,"twenty":-17.593348,"median":-6.089351,"eighty":-4.961191,"marketCap":437783972},{"date":"2024-03-28","current":-69.405148,"twenty":-18.101359,"median":-6.099956,"eighty":-4.961191,"marketCap":463973412},{"date":"2024-04-05","current":-66.890118,"twenty":-18.959167,"median":-6.113366,"eighty":-4.968258,"marketCap":447160438},{"date":"2024-04-12","current":-64.133258,"twenty":-19.427711,"median":-6.12749,"eighty":-4.972184,"marketCap":428730832},{"date":"2024-04-19","current":-57.740708,"twenty":-19.862568,"median":-6.151102,"eighty":-4.983342,"marketCap":385996632},{"date":"2024-04-26","current":-59.922347,"twenty":-20.184117,"median":-6.16971,"eighty":-4.990199,"marketCap":400580888},{"date":"2024-05-03","current":-65.74005,"twenty":-20.444419,"median":-6.184272,"eighty":-4.992718,"marketCap":439472236},{"date":"2024-05-10","current":19.415556,"twenty":-20.444419,"median":-6.175043,"eighty":-4.972184,"marketCap":455974329},{"date":"2024-05-17","current":20.21327,"twenty":-20.380109,"median":-6.165519,"eighty":-4.951776,"marketCap":474708650},{"date":"2024-05-24","current":20.307914,"twenty":-20.2913,"median":-6.137664,"eighty":-4.92478,"marketCap":476931366},{"date":"2024-05-31","current":21.13267,"twenty":-20.263739,"median":-6.121053,"eighty":-4.910399,"marketCap":496300749},{"date":"2024-06-07","current":21.36252,"twenty":-20.202491,"median":-6.101682,"eighty":-4.850628,"marketCap":501698774},{"date":"2024-06-14","current":22.241358,"twenty":-20.073872,"median":-6.099956,"eighty":-4.811533,"marketCap":522338281},{"date":"2024-06-21","current":19.523721,"twenty":-19.926878,"median":-6.084547,"eighty":-4.791677,"marketCap":458514576},{"date":"2024-06-28","current":21.190193,"twenty":-19.908503,"median":-6.084547,"eighty":-4.774893,"marketCap":497651675},{"date":"2024-07-05","current":21.220101,"twenty":-19.884004,"median":-6.074028,"eighty":-4.75366,"marketCap":498354077},{"date":"2024-07-12","current":25.975557,"twenty":-19.868693,"median":-6.049635,"eighty":-4.708476,"marketCap":610035963},{"date":"2024-07-15","current":25.646563,"twenty":-19.86563,"median":-6.041344,"eighty":-4.695302,"marketCap":602309543},{"date":"2024-08-02","current":23.867006,"twenty":-19.862568,"median":-6.039378,"eighty":-4.672517,"marketCap":560516636},{"date":"2024-08-09","current":21.608912,"twenty":-19.826255,"median":-6.030346,"eighty":-4.59214,"marketCap":507485300},{"date":"2024-08-16","current":5.477968,"twenty":-19.64186,"median":-6.024748,"eighty":-4.554742,"marketCap":572140896},{"date":"2024-08-23","current":5.427433,"twenty":-19.500935,"median":-6.016566,"eighty":-4.515022,"marketCap":566862843},{"date":"2024-08-30","current":5.895722,"twenty":-19.427711,"median":-6.004236,"eighty":-4.471291,"marketCap":615772797},{"date":"2024-09-06","current":5.184866,"twenty":-19.32359,"median":-5.996942,"eighty":-4.404766,"marketCap":541528191},{"date":"2024-09-13","current":5.00631,"twenty":-19.188845,"median":-5.984239,"eighty":-4.33112,"marketCap":522879072},{"date":"2024-09-20","current":5.053476,"twenty":-19.038789,"median":-5.963335,"eighty":-4.288277,"marketCap":527805255},{"date":"2024-09-27","current":5.312888,"twenty":-18.96223,"median":-5.941515,"eighty":-4.265242,"marketCap":554899258},{"date":"2024-10-04","current":5.53861,"twenty":-18.944963,"median":-5.936157,"eighty":-4.226961,"marketCap":578474559},{"date":"2024-10-11","current":5.326364,"twenty":-18.856806,"median":-5.931781,"eighty":-4.189868,"marketCap":556306738},{"date":"2024-10-18","current":5.939519,"twenty":-18.609029,"median":-5.915524,"eighty":-4.126724,"marketCap":620347109},{"date":"2024-10-25","current":5.673369,"twenty":-18.19595,"median":-5.907226,"eighty":-4.100192,"marketCap":592549366},{"date":"2024-10-31","current":5.80476,"twenty":-17.843071,"median":-5.891429,"eighty":-4.019982,"marketCap":606272302},{"date":"2024-11-08","current":12.390042,"twenty":-17.597525,"median":-5.862704,"eighty":-3.976074,"marketCap":680845207},{"date":"2024-11-15","current":12.267624,"twenty":-17.595854,"median":-5.851076,"eighty":-3.881511,"marketCap":674118187},{"date":"2024-11-22","current":11.629759,"twenty":-17.593348,"median":-5.835599,"eighty":-3.819187,"marketCap":639066874},{"date":"2024-11-29","current":12.815285,"twenty":-17.245441,"median":-5.821992,"eighty":-3.767275,"marketCap":704212749},{"date":"2024-12-06","current":13.092338,"twenty":-15.736155,"median":-5.81239,"eighty":-3.495412,"marketCap":719437057},{"date":"2024-12-13","current":11.67486,"twenty":-15.214231,"median":-5.797942,"eighty":-3.367358,"marketCap":641545250},{"date":"2024-12-20","current":11.133642,"twenty":-14.879355,"median":-5.778442,"eighty":-3.167818,"marketCap":611804741},{"date":"2024-12-27","current":11.430023,"twenty":-14.360448,"median":-5.768112,"eighty":-2.950607,"marketCap":628091210},{"date":"2025-01-03","current":11.249617,"twenty":-13.956183,"median":-5.754982,"eighty":-2.907357,"marketCap":618177707},{"date":"2025-01-10","current":10.450675,"twenty":-13.687679,"median":-5.750196,"eighty":-2.871796,"marketCap":574275052},{"date":"2025-01-17","current":8.079622,"twenty":-13.52175,"median":-5.745698,"eighty":4.66739,"marketCap":443983302},{"date":"2025-01-24","current":8.324459,"twenty":-13.470462,"median":-5.734949,"eighty":4.930845,"marketCap":457437341},{"date":"2025-01-31","current":8.614397,"twenty":-13.333193,"median":-5.728214,"eighty":5.00631,"marketCap":473369756},{"date":"2025-02-07","current":8.685271,"twenty":-13.061672,"median":-5.704997,"eighty":5.067626,"marketCap":477264347},{"date":"2025-02-14","current":8.13761,"twenty":-12.882167,"median":-5.680564,"eighty":5.23877,"marketCap":447169785},{"date":"2025-02-21","current":8.421105,"twenty":-12.823337,"median":-5.663281,"eighty":5.326364,"marketCap":462748146},{"date":"2025-02-28","current":6.463236,"twenty":-12.636289,"median":-5.655945,"eighty":5.420021,"marketCap":424156296},{"date":"2025-03-07","current":5.656685,"twenty":-12.097773,"median":-5.638438,"eighty":5.496161,"marketCap":371225587},{"date":"2025-03-14","current":5.873832,"twenty":-11.969554,"median":-5.62503,"eighty":5.544674,"marketCap":385476089},{"date":"2025-03-21","current":5.651256,"twenty":-11.577357,"median":-5.617686,"eighty":5.571626,"marketCap":370869324},{"date":"2025-03-28","current":5.406965,"twenty":-11.517019,"median":-5.599973,"eighty":5.615422,"marketCap":354837509},{"date":"2025-04-04","current":4.353801,"twenty":-11.27265,"median":-5.589567,"eighty":5.571626,"marketCap":285722573},{"date":"2025-04-11","current":4.261514,"twenty":-11.237955,"median":-5.571525,"eighty":5.568257,"marketCap":279666109},{"date":"2025-04-17","current":4.266943,"twenty":-11.147449,"median":-5.559289,"eighty":5.565562,"marketCap":280022372},{"date":"2025-04-25","current":4.864097,"twenty":-11.079568,"median":-5.509464,"eighty":5.565562,"marketCap":319211253},{"date":"2025-05-02","current":4.962433,"twenty":-10.78542,"median":-5.491157,"eighty":5.545348,"marketCap":325664639},{"date":"2025-05-09","current":12.517294,"twenty":-10.332885,"median":-5.478703,"eighty":5.545348,"marketCap":310191070},{"date":"2025-05-16","current":11.552558,"twenty":-10.204667,"median":-5.459354,"eighty":5.5723,"marketCap":286283941},{"date":"2025-05-23","current":10.841194,"twenty":-10.031195,"median":-5.452073,"eighty":5.656685,"marketCap":268655619},{"date":"2025-05-30","current":11.239558,"twenty":-9.946722,"median":-5.429059,"eighty":5.695138,"marketCap":278527479},{"date":"2025-06-06","current":11.552558,"twenty":-9.702353,"median":-5.399443,"eighty":5.718514,"marketCap":286283941},{"date":"2025-06-13","current":11.168421,"twenty":-9.387087,"median":-5.353381,"eighty":5.773165,"marketCap":276764647},{"date":"2025-06-20","current":10.001784,"twenty":-9.232949,"median":-5.335361,"eighty":5.826994,"marketCap":247854200},{"date":"2025-06-27","current":9.987556,"twenty":-9.158624,"median":-5.321012,"eighty":5.856345,"marketCap":247501633},{"date":"2025-07-03","current":10.286329,"twenty":-9.145735,"median":-5.311468,"eighty":5.87166,"marketCap":254905528},{"date":"2025-07-11","current":9.617647,"twenty":-9.135788,"median":-5.304931,"eighty":5.919979,"marketCap":238334906},{"date":"2025-07-18","current":9.07701,"twenty":-9.127043,"median":-5.286124,"eighty":5.964912,"marketCap":224937382},{"date":"2025-07-25","current":9.091237,"twenty":-9.122507,"median":-5.284126,"eighty":6.126809,"marketCap":225289948},{"date":"2025-08-01","current":8.365645,"twenty":-9.060726,"median":-5.279034,"eighty":7.783241,"marketCap":207309060},{"date":"2025-08-08","current":-2.568826,"twenty":-8.957729,"median":-5.271746,"eighty":7.890195,"marketCap":188431117},{"date":"2025-08-15","current":-2.544592,"twenty":-8.921801,"median":-5.25003,"eighty":7.855403,"marketCap":186653465},{"date":"2025-08-22","current":-2.845096,"twenty":-8.884503,"median":-5.233243,"eighty":7.783241,"marketCap":208696350},{"date":"2025-08-29","current":-2.738466,"twenty":-8.846163,"median":-5.226635,"eighty":7.239487,"marketCap":200874681},{"date":"2025-09-05","current":-2.530052,"twenty":-8.844007,"median":-5.219365,"eighty":6.478122,"marketCap":185586874},{"date":"2025-09-12","current":-2.583367,"twenty":-8.817897,"median":-5.209215,"eighty":6.400728,"marketCap":189497708},{"date":"2025-09-19","current":-2.689997,"twenty":-8.689404,"median":-5.18342,"eighty":6.138752,"marketCap":197319377},{"date":"2025-09-26","current":-2.704538,"twenty":-8.540746,"median":-5.163374,"eighty":6.074163,"marketCap":198385968},{"date":"2025-10-03","current":-2.869331,"twenty":-8.521236,"median":-5.151903,"eighty":6.002856,"marketCap":210474002},{"date":"2025-10-10","current":-3.291006,"twenty":-8.454865,"median":-5.136156,"eighty":5.982572,"marketCap":241405148},{"date":"2025-10-17","current":-2.995348,"twenty":-8.451848,"median":-5.106483,"eighty":5.965516,"marketCap":219717793},{"date":"2025-10-24","current":-3.101979,"twenty":-8.421679,"median":-5.09094,"eighty":5.960407,"marketCap":227539462},{"date":"2025-10-31","current":-3.344321,"twenty":-8.347461,"median":-5.083828,"eighty":5.947605,"marketCap":245315982},{"date":"2025-11-07","current":-2.388417,"twenty":-8.284705,"median":-5.064425,"eighty":5.937498,"marketCap":247093634},{"date":"2025-11-14","current":-3.043492,"twenty":-8.046074,"median":-5.04517,"eighty":5.924695,"marketCap":314864470},{"date":"2025-11-21","current":-3.178681,"twenty":-7.966471,"median":-5.003716,"eighty":5.903808,"marketCap":328850477},{"date":"2025-11-28","current":-3.559984,"twenty":-7.913544,"median":-4.993085,"eighty":5.895722,"marketCap":368298190},{"date":"2025-12-05","current":-3.521854,"twenty":-7.90428,"median":-4.979361,"eighty":5.875508,"marketCap":364353419},{"date":"2025-12-12","current":-3.74717,"twenty":-7.859027,"median":-4.961191,"eighty":5.873832,"marketCap":387663431},{"date":"2025-12-19","current":-3.799165,"twenty":-7.813773,"median":-4.950413,"eighty":5.868403,"marketCap":393042664},{"date":"2025-12-26","current":-3.667443,"twenty":-7.801706,"median":-4.930396,"eighty":5.868403,"marketCap":379415273},{"date":"2026-01-02","current":-3.563451,"twenty":-7.789638,"median":-4.923318,"eighty":5.865146,"marketCap":368656805},{"date":"2026-01-09","current":-3.646644,"twenty":-7.747401,"median":-4.915123,"eighty":5.856345,"marketCap":377263579},{"date":"2026-01-16","current":-3.750636,"twenty":-7.718741,"median":-4.871065,"eighty":5.848783,"marketCap":388022046},{"date":"2026-01-23","current":-4.059145,"twenty":-7.664436,"median":-4.849564,"eighty":5.842345,"marketCap":419938832},{"date":"2026-01-30","current":-4.041813,"twenty":-7.572419,"median":-4.820781,"eighty":5.835531,"marketCap":418145754},{"date":"2026-02-06","current":-3.490657,"twenty":-7.546777,"median":-4.796098,"eighty":5.82969,"marketCap":361125878},{"date":"2026-02-13","current":-3.743703,"twenty":-7.529048,"median":-4.778229,"eighty":5.814866,"marketCap":387304815}],"updateTime":1771240692899},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"TRDA\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2610995959","title":"Entrada Therapeutics Initiated at Buy by Guggenheim","url":"https://stock-news.laohu8.com/highlight/detail?id=2610995959","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610995959?lang=en_us&edition=fundamental","pubTime":"2026-02-11 23:01","pubTimestamp":1770822060,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/TRDA/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  February 11, 2026 10:01 ET (15:01 GMT)","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TRDA","BK4139"],"gpt_icon":0},{"id":"2610132932","title":"Guggenheim Initiates Coverage on Entrada Therapeutics With Buy Rating, $20 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2610132932","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610132932?lang=en_us&edition=fundamental","pubTime":"2026-02-11 20:22","pubTimestamp":1770812538,"startTime":"0","endTime":"0","summary":"Entrada Therapeutics Inc (TRDA) has an average rating of Buy and mean price target of $18.50, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["TRDA"],"gpt_icon":0},{"id":"2608361365","title":"Entrada Therapeutics to Present at Upcoming Investor Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2608361365","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608361365?lang=en_us&edition=fundamental","pubTime":"2026-02-04 20:00","pubTimestamp":1770206400,"startTime":"0","endTime":"0","summary":"BOSTON, Feb.  04, 2026  (GLOBE NEWSWIRE) -- Entrada Therapeutics, Inc. (Nasdaq: TRDA) today announced the Company will participate in two upcoming investor conferences. Guggenheim Emerging Outlook: Bi","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/02/04/3231902/0/en/Entrada-Therapeutics-to-Present-at-Upcoming-Investor-Conferences.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TRDA","BK4139"],"gpt_icon":0},{"id":"2606716577","title":"Oppenheimer Initiates Coverage on Entrada Therapeutics With Outperform Rating, $21 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2606716577","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606716577?lang=en_us&edition=fundamental","pubTime":"2026-01-28 20:24","pubTimestamp":1769603060,"startTime":"0","endTime":"0","summary":"Entrada Therapeutics Inc (TRDA) has an average rating of Buy and mean price target of $18, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from maj","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["OPY","TRDA"],"gpt_icon":0},{"id":"2603521707","title":"Entrada Therapeutics: Advancing DMD and DM1 Pipeline with Emerging Ophthalmology Assets Supports Buy Rating and $20 Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2603521707","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603521707?lang=en_us&edition=fundamental","pubTime":"2026-01-13 06:35","pubTimestamp":1768257319,"startTime":"0","endTime":"0","summary":"Ram Selvaraju, an analyst from H.C. Wainwright, reiterated the Buy rating on Entrada Therapeutics Inc. The associated price target remains the same...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/entrada-therapeutics-advancing-dmd-and-dm1-pipeline-with-emerging-ophthalmology-assets-supports-buy-rating-and-20-target-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/entrada-therapeutics-advancing-dmd-and-dm1-pipeline-with-emerging-ophthalmology-assets-supports-buy-rating-and-20-target-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TRDA"],"gpt_icon":0},{"id":"2601921361","title":"Entrada Therapeutics unveils pipeline advances for Duchenne and myotonic dystrophy therapies","url":"https://stock-news.laohu8.com/highlight/detail?id=2601921361","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601921361?lang=en_us&edition=fundamental","pubTime":"2026-01-08 20:47","pubTimestamp":1767876434,"startTime":"0","endTime":"0","summary":"Entrada Therapeutics Inc. provided an update on its expanding pipeline of intracellular therapeutics, highlighting several clinical-stage programs targeting diseases with significant unmet medical needs. The company’s Duchenne muscular dystrophy  franchise includes multiple candidates, with clinical data expected for ENTR-601-44 and ENTR-601-45 in 2026. Additionally, ENTR-601-50 has received authorization for a Phase 1/2 study in the U.K., with a European Union filing anticipated later in the year. The myotonic dystrophy type 1  program, partnered with Vertex, has progressed to the multiple ascending dose phase, with completion of enrollment and dosing expected in the first half of 2026. The company is utilizing ex-U.S. clinical data to inform discussions with regulatory agencies regarding potential accelerated approval pathways and plans to initiate global registrational studies for broader approval. You can access the full presentation through the link below.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260108:nNDL3B2G6r:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","TRDA"],"gpt_icon":0},{"id":"2601536994","title":"Entrada Therapeutics reports progress across development portfolio","url":"https://stock-news.laohu8.com/highlight/detail?id=2601536994","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601536994?lang=en_us&edition=fundamental","pubTime":"2026-01-08 20:16","pubTimestamp":1767874570,"startTime":"0","endTime":"0","summary":"Entrada Therapeutics (TRDA) reported progress across its robust development portfolio of RNA-based programs for the potential treatment of neuromus...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/entrada-therapeutics-reports-progress-across-development-portfolio-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/entrada-therapeutics-reports-progress-across-development-portfolio-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE0009354923.USD","BK4139","RNA","BK4588","BK4505","TRDA","BK4585"],"gpt_icon":0},{"id":"2601698463","title":"Entrada Therapeutics Inc - Has Cash Runway Into Q3 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2601698463","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601698463?lang=en_us&edition=fundamental","pubTime":"2026-01-08 20:09","pubTimestamp":1767874156,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260108:nFWN3Y81RN:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","TRDA"],"gpt_icon":0},{"id":"2601369869","title":"Entrada Therapeutics Inc - Expects to Initiate Global Phase 1/2 Mad Clinical Study of Entr-601-50 by End of 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2601369869","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601369869?lang=en_us&edition=fundamental","pubTime":"2026-01-08 20:09","pubTimestamp":1767874156,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260108:nFWN3Y81RN:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","TRDA"],"gpt_icon":0},{"id":"2601036986","title":"Entrada Therapeutics Inc - on Track to Report Elevate-44-201 Data From First Cohort in Q2 2026 and Elevate-45-201 Data From First Cohort in Mid-2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2601036986","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601036986?lang=en_us&edition=fundamental","pubTime":"2026-01-08 20:09","pubTimestamp":1767874156,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260108:nFWN3Y81RN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","TRDA"],"gpt_icon":0},{"id":"2601369386","title":"Entrada Therapeutics Highlights Progress Across its Portfolio of RNA-based Therapeutics for the Treatment of Neuromuscular and Ocular Diseases","url":"https://stock-news.laohu8.com/highlight/detail?id=2601369386","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601369386?lang=en_us&edition=fundamental","pubTime":"2026-01-08 20:00","pubTimestamp":1767873600,"startTime":"0","endTime":"0","summary":"-- Company on track to report ELEVATE-44-201 data from the first cohort in Q2 2026 and ELEVATE-45-201 data from the first cohort in mid-2026 – -- Expects to initiate global Phase 1/2 MAD clinical stud","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/01/08/3215189/0/en/Entrada-Therapeutics-Highlights-Progress-Across-its-Portfolio-of-RNA-based-Therapeutics-for-the-Treatment-of-Neuromuscular-and-Ocular-Diseases.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4505","LU2065732104.USD","IE0009354923.USD","TRDA","PRGS","RNA","BK4097","BK4585","BK4588","BK4139"],"gpt_icon":0},{"id":"2591962511","title":"Entrada Therapeutics Unveils Pipeline Progress and Clinical Milestones for Duchenne and Myotonic Dystrophy Programs","url":"https://stock-news.laohu8.com/highlight/detail?id=2591962511","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591962511?lang=en_us&edition=fundamental","pubTime":"2025-12-16 01:45","pubTimestamp":1765820739,"startTime":"0","endTime":"0","summary":"Entrada Therapeutics Inc. has provided an update on its clinical development pipeline, outlining plans to advance four clinical-stage programs by the end of 2025. Key milestones expected in 2026 include data readouts for ENTR-601-44 and ENTR-601-45, as well as progress on ENTR-601-50 and Vertex-partnered VX-670 for myotonic dystrophy type 1 . The company highlighted its strategy around its EEV platform, emphasizing improvements in endosomal escape and the development of novel PMO conjugates. Entrada also noted that ongoing and planned ex-U.S. studies are designed to generate data supporting future regulatory discussions and potential accelerated approval pathways. You can access the full presentation through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as fina","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251215:nNDLG6xjk:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","TRDA"],"gpt_icon":0},{"id":"2589883089","title":"Entrada Therapeutics Grants Stock Options and RSUs to New Employees Under 2025 Inducement Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=2589883089","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589883089?lang=en_us&edition=fundamental","pubTime":"2025-12-05 05:30","pubTimestamp":1764883807,"startTime":"0","endTime":"0","summary":"Entrada Therapeutics Inc. has granted a total of 40,650 restricted stock units  and options to purchase 38,850 shares of its common stock to five newly-hired non-executive employees under the 2025 Inducement Equity Plan. The stock options have an exercise price of $9.91 per share, matching the closing price on December 1, 2025. For each employee, one-fourth of the stock options will vest on the one-year anniversary of the vesting commencement date, with the remaining 75% vesting in equal monthly installments over the next three years. Similarly, one-fourth of the RSUs will vest after one year, with 6.25% vesting quarterly thereafter. Vesting is contingent on continued employment or service with the company.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251204:nNDLbHFW8z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","IE00B64PRP62.GBP","LU2095319765.USD","LU0314104364.USD","LU2210150020.SGD","IE00BKPKM429.USD","TRDA","BK4588","IE00B3QW5Z07.USD","BK4112","LU2210149790.SGD","IE00BGHQF748.EUR","NDAQ","BK4585"],"gpt_icon":0},{"id":"2586188134","title":"Entrada Therapeutics CFO Kory James Wentworth Reports Disposal of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2586188134","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586188134?lang=en_us&edition=fundamental","pubTime":"2025-11-25 05:31","pubTimestamp":1764019877,"startTime":"0","endTime":"0","summary":"Kory James Wentworth, Chief Financial Officer of Entrada Therapeutics Inc., reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Entrada Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on November 24, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251124:nNDLb3M6ps:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Entrada Therapeutics CFO Kory James Wentworth Reports Disposal of Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TRDA","BK4139"],"gpt_icon":0},{"id":"2584995281","title":"Major Stock Sell-Offs at Entrada Therapeutics Inc!","url":"https://stock-news.laohu8.com/highlight/detail?id=2584995281","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584995281?lang=en_us&edition=fundamental","pubTime":"2025-11-19 10:14","pubTimestamp":1763518440,"startTime":"0","endTime":"0","summary":"New insider activity at Entrada Therapeutics Inc ( ($TRDA) ) has taken place on November 18, 2025. Director Kush Parmar and significant shareholder...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/major-stock-sell-offs-at-entrada-therapeutics-inc-insider-trading?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/major-stock-sell-offs-at-entrada-therapeutics-inc-insider-trading?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","TRDA"],"gpt_icon":0},{"id":"2584696643","title":"Director and 10% Owner Kush Parmar Reports Disposal of Entrada Therapeutics Inc. Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2584696643","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584696643?lang=en_us&edition=fundamental","pubTime":"2025-11-19 05:37","pubTimestamp":1763501821,"startTime":"0","endTime":"0","summary":"Kush Parmar, Director and 10% Owner, reported a disposal of common shares of Entrada Therapeutics Inc. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Entrada Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on November 18, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251118:nNDLbGMv1F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TRDA","BK4139"],"gpt_icon":0},{"id":"2584796616","title":"5AM Ventures V, L.P. Reports Sale of Entrada Therapeutics Inc. Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2584796616","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584796616?lang=en_us&edition=fundamental","pubTime":"2025-11-19 05:35","pubTimestamp":1763501729,"startTime":"0","endTime":"0","summary":"5AM Ventures V, L.P. reported the disposal of common shares of Entrada Therapeutics Inc. , according to a recent SEC filing. The transaction was disclosed by 5AM Ventures V, L.P. and other reporting beneficial owners. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Entrada Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on November 18, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251118:nNDL4L5gLY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"5AM Ventures V, L.P. Reports Sale of Entrada Therapeutics Inc. Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TRDA","BK4139"],"gpt_icon":0},{"id":"2583897465","title":"Baker Bros. Advisors LP Acquires Common Shares of Entrada Therapeutics Inc","url":"https://stock-news.laohu8.com/highlight/detail?id=2583897465","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583897465?lang=en_us&edition=fundamental","pubTime":"2025-11-13 06:35","pubTimestamp":1762986910,"startTime":"0","endTime":"0","summary":"Baker Bros. Advisors LP and other reporting beneficial owners have reported the acquisition of common shares of Entrada Therapeutics Inc. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Entrada Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on November 12, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251112:nNDL5WTKH2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Baker Bros. Advisors LP Acquires Common Shares of Entrada Therapeutics Inc","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","TRDA"],"gpt_icon":0},{"id":"2581009013","title":"Promising Advancements and Strategic Positioning Drive Buy Rating for Entrada Therapeutics Inc.","url":"https://stock-news.laohu8.com/highlight/detail?id=2581009013","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581009013?lang=en_us&edition=fundamental","pubTime":"2025-11-07 01:15","pubTimestamp":1762449346,"startTime":"0","endTime":"0","summary":"TD Cowen analyst Joseph Thome has maintained their bullish stance on TRDA stock, giving a Buy rating on October 28. Joseph Thome has given his Buy ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/promising-advancements-and-strategic-positioning-drive-buy-rating-for-entrada-therapeutics-inc-ratings?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/promising-advancements-and-strategic-positioning-drive-buy-rating-for-entrada-therapeutics-inc-ratings?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TRDA"],"gpt_icon":0},{"id":"2581809908","title":"BRIEF-Entrada Therapeutics may issue up to $400 million in securities - SEC filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2581809908","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581809908?lang=en_us&edition=fundamental","pubTime":"2025-11-06 22:07","pubTimestamp":1762438030,"startTime":"0","endTime":"0","summary":"BRIEF-Entrada Therapeutics may issue up to $400 million in securities - SEC filingNov 6  - Entrada Therapeutics Inc TRDA.O:ENTRADA THERAPEUTICS INC - MAY ISSUE UP TO $400 MILLION IN SECURITIES - SEC FILINGSource text: [ID:n0001104659-25-107397]Further company coverage: TRDA.O ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251106:nFWN3WI16Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TRDA","BK4139"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":37,"code":"91000000","status":"200"}]}}